OPRL1 and diabetic neuropathy: JTC-801, a nociceptin/orphanin FQ receptor (ORL-1) antagonist, was i.t. administered to mice with diabetic neuropathy, and the time course of the pain threshold was measured immediately after administration (Figure 5).